MedTrace Logo

A Prospective Validation Cohort Study of a Prediction System on nSLN Metastasis in Early Breast Cancer

NCT03280134 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 388

Last updated 2019-06-04

No results posted yet for this study

Summary

In the previous study, the investigator established a predictive model for non-sentinel lymph node involvement in early breast cancer (cT1-2cN0, 1-2 SLNs involvement). To validation the clinical value of the model, the investigator design a prospectively research using the model guiding for further axillary lymph node dissection in SLN-positve early breast cancer.

Conditions

Interventions

PROCEDURE

axillary lymph node dissection (ALND)

If the patients had predictive nSLN+, need further axillary lymph node dissection.

Sponsors & Collaborators

  • Zhejiang Cancer Hospital

    lead OTHER

Principal Investigators

  • XF YU, M.D. · Zhejiang Cancer Hospital

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-10-15
Primary Completion
2019-12-31
Completion
2020-06-30

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03280134 on ClinicalTrials.gov